Johnson Matthey PLC (LON:JMAT - Get Free Report)'s stock price traded up 29% during trading on Thursday . The stock traded as high as GBX 1,888 ($25.55) and last traded at GBX 1,792.32 ($24.25). 3,427,063 shares traded hands during mid-day trading, an increase of 25% from the average session volume of 2,743,881 shares. The stock had previously closed at GBX 1,389 ($18.80).
Johnson Matthey Price Performance
The company's 50-day moving average price is GBX 1,307.66 and its two-hundred day moving average price is GBX 1,375.64. The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The company has a market capitalization of £2.89 billion, a P/E ratio of 29.40, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) EPS for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. As a group, sell-side analysts expect that Johnson Matthey PLC will post 173.4112903 EPS for the current year.
Johnson Matthey Increases Dividend
The company also recently announced a dividend, which was paid on Wednesday, April 16th. Stockholders of record on Thursday, April 10th were issued a dividend of GBX 32 ($0.43) per share. The ex-dividend date was Thursday, April 10th. This represents a dividend yield of 1.88%. This is an increase from Johnson Matthey's previous dividend of $22.00. Johnson Matthey's dividend payout ratio (DPR) is currently 130.84%.
Insider Activity
In other Johnson Matthey news, insider Liam Condon purchased 27 shares of the company's stock in a transaction dated Wednesday, March 19th. The stock was bought at an average cost of GBX 1,445 ($19.55) per share, for a total transaction of £390.15 ($527.94). Over the last 90 days, insiders acquired 75 shares of company stock valued at $99,927. 0.61% of the stock is owned by company insiders.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
See Also
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
